| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 3.037 | 6.487 | 7.814 | 10.769 |
| Total Income - EUR | - | - | - | - | - | 0 | 3.037 | 6.487 | 7.814 | 10.769 |
| Total Expenses - EUR | - | - | - | - | - | 103 | 2.929 | 2.155 | 6.821 | 9.799 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -103 | 108 | 4.332 | 993 | 969 |
| Net Profit/Loss - EUR | - | - | - | - | - | -103 | 108 | 4.141 | 852 | 798 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dopamina S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 0 | 0 | 0 | 0 | 2.001 |
| Current Assets | - | - | - | - | - | 145 | 148 | 4.415 | 6.166 | 4.333 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | -379 | 225 |
| Cash | - | - | - | - | - | 145 | 148 | 4.415 | 6.546 | 4.108 |
| Shareholders Funds | - | - | - | - | - | -62 | 47 | 4.188 | 5.028 | 5.879 |
| Social Capital | - | - | - | - | - | 41 | 0 | 0 | 0 | 40 |
| Debts | - | - | - | - | - | 207 | 101 | 226 | 1.139 | 455 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9623 - 9623" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Dopamina S.r.l.